Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series

Date
2018
Author
Gharavi, Ali G.
Caliskan, Yaşar Kerem
Li, Yifu
Appel, Gerald B.
Ozluk, Yasemin
Avasare, Rupali S.
Canetta, Pietro A.
Bomback, Andrew S.
Marasa, Maddalena
Metadata
Show full item record
Abstract
Background and objectives C3 glomerulopathy is a form of complement-mediated GN. Immunosuppressive therapy may be beneficial in the treatment of C3 glomerulopathy. Mycophenolate mofetil is an attractive treatment option given its role in the treatment of other complement-mediated diseases and the results of the Spanish Group for the Study of Glomerular Diseases C3 Study. Here, we study the outcomes of patients with C3 glomerulopathy treated with steroids and mycophenolate mofetil.
URI
http://hdl.handle.net/20.500.12627/129671
https://doi.org/10.2215/cjn.09080817
Collections